These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 17337886)

  • 1. Associations between the CYBA 242C/T and the MPO -463G/A polymorphisms, oxidative stress and cardiovascular disease in chronic kidney disease patients.
    Grahl DA; Axelsson J; Nordfors L; Heimburger O; Bárány P; Gao YZ; Qureshi AR; Kato S; Watanabe M; Suliman M; Riella MC; Lindholm B; Stenvinkel P; Pecoits-Filho R
    Blood Purif; 2007; 25(2):210-8. PubMed ID: 17337886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CYP1A1, CYP1A2 and CYBA gene polymorphisms associated with oxidative stress in COPD.
    Vibhuti A; Arif E; Mishra A; Deepak D; Singh B; Rahman I; Mohammad G; Pasha MA
    Clin Chim Acta; 2010 Apr; 411(7-8):474-80. PubMed ID: 20080081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloperoxidase and CYBA genetic variants in polycystic ovary syndrome.
    Ma W; Li S; Liu H; Bai H; Liu Q; Hu K; Guan L; Fan P
    Eur J Clin Invest; 2021 Apr; 51(4):e13438. PubMed ID: 33091151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NADPH oxidase CYBA polymorphisms, oxidative stress and cardiovascular diseases.
    San José G; Fortuño A; Beloqui O; Díez J; Zalba G
    Clin Sci (Lond); 2008 Feb; 114(3):173-82. PubMed ID: 18184111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of matrix Gla protein, Klotho gene polymorphisms, and oxidative stress in chronic kidney disease.
    Karsli Ceppioğlu S; Yurdun T; Canbakan M
    Ren Fail; 2011; 33(9):866-74. PubMed ID: 21859400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The C242T CYBA polymorphism of NADPH oxidase is associated with essential hypertension.
    Moreno MU; San José G; Fortuño A; Beloqui O; Díez J; Zalba G
    J Hypertens; 2006 Jul; 24(7):1299-306. PubMed ID: 16794479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phospholipid plasmalogen, a surrogate marker of oxidative stress, is associated with increased cardiovascular mortality in patients on renal replacement therapy.
    Stenvinkel P; Diczfalusy U; Lindholm B; Heimbürger O
    Nephrol Dial Transplant; 2004 Apr; 19(4):972-6. PubMed ID: 15031358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A functional variant of the myeloperoxidase gene is associated with cardiovascular disease in end-stage renal disease patients.
    Pecoits-Filho R; Stenvinkel P; Marchlewska A; Heimburger O; Bárány P; Hoff CM; Holmes CJ; Suliman M; Lindholm B; Schalling M; Nordfors L
    Kidney Int Suppl; 2003 May; (84):S172-6. PubMed ID: 12694338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms in NADPH oxidase CYBA gene modify the risk of ESRD in patients with chronic glomerulonephritis.
    Zhou H; Chen M; Zhu Y; Wang B; Liu XN; Zuo Z; Tang FY
    Ren Fail; 2016; 38(2):262-7. PubMed ID: 26627442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel CYBA variant, the -675A/T polymorphism, is associated with essential hypertension.
    Moreno MU; San José G; Fortuño A; Beloqui O; Redón J; Chaves FJ; Corella D; Díez J; Zalba G
    J Hypertens; 2007 Aug; 25(8):1620-6. PubMed ID: 17620958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between oestrogen receptor alpha gene polymorphism and mortality in female end-stage renal disease patients.
    Kato S; Lindholm B; Axelsson J; Qureshi RA; Barany P; Heimbürger O; Gustafsson JA; Stenvinkel P; Nordfors L
    Nephrol Dial Transplant; 2007 Sep; 22(9):2571-7. PubMed ID: 17452407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional polymorphism of the myeloperoxidase gene in hypertensive nephrosclerosis dialysis patients.
    Doi K; Noiri E; Maeda R; Nakao A; Kobayashi S; Tokunaga K; Fujita T
    Hypertens Res; 2007 Dec; 30(12):1193-8. PubMed ID: 18344624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between MPO-463G > A polymorphism and chronic kidney disease: a meta-analysis.
    Qin J; Xing J; Li W; Zhang K; Wu Z
    Ren Fail; 2018 Nov; 40(1):541-546. PubMed ID: 30278820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NADPH oxidase p22phox and catalase gene variants are associated with biomarkers of oxidative stress and adverse outcomes in acute renal failure.
    Perianayagam MC; Liangos O; Kolyada AY; Wald R; MacKinnon RW; Li L; Rao M; Balakrishnan VS; Bonventre JV; Pereira BJ; Jaber BL
    J Am Soc Nephrol; 2007 Jan; 18(1):255-63. PubMed ID: 17151330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma myeloperoxidase level and peripheral arterial disease.
    Haslacher H; Perkmann T; Gruenewald J; Exner M; Endler G; Scheichenberger V; Wagner O; Schillinger M
    Eur J Clin Invest; 2012 May; 42(5):463-9. PubMed ID: 21950958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genetic polymorphisms of MPO, NQO1, GSTP1, UGT1A6 associated with susceptibility of chronic benzene poisoning].
    Sun P; Zhang Z; Wan J; Shao M
    Wei Sheng Yan Jiu; 2007 Jan; 36(1):11-5. PubMed ID: 17424838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of alcohol dehydrogenase 1C polymorphism on the alcohol-cardiovascular disease association (from the Framingham Offspring Study).
    Djoussé L; Levy D; Herbert AG; Wilson PW; D'Agostino RB; Cupples LA; Karamohamed S; Ellison RC
    Am J Cardiol; 2005 Jul; 96(2):227-32. PubMed ID: 16018848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of rs11780592 Polymorphism in the Human Soluble Epoxide Hydrolase Gene (EPHX2) with Oxidized LDL and Mortality in Patients with Diabetic Chronic Kidney Disease.
    Roumeliotis S; Roumeliotis A; Stamou A; Panagoutsos S; Manolopoulos VG; Tsetsos F; Georgitsi M; Liakopoulos V
    Oxid Med Cell Longev; 2021; 2021():8817502. PubMed ID: 34040693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of inflammation on epigenetic DNA methylation - a novel risk factor for cardiovascular disease?
    Stenvinkel P; Karimi M; Johansson S; Axelsson J; Suliman M; Lindholm B; Heimbürger O; Barany P; Alvestrand A; Nordfors L; Qureshi AR; Ekström TJ; Schalling M
    J Intern Med; 2007 May; 261(5):488-99. PubMed ID: 17444888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low plasma DHEA-S increases mortality risk among male hemodialysis patients.
    Hsu HJ; Yen CH; Chen CK; Hsu KH; Hsiao CC; Lee CC; Wu IW; Sun CY; Chou CC; Hsieh MF; Chen CY; Hsu CY; Tsai CJ; Wu MS
    Exp Gerontol; 2012 Dec; 47(12):950-7. PubMed ID: 22974561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.